Dailypharm Live Search Close

Sanofi & 4 other companies will participate in NIP

By Lee, Tak-Sun | translator Choi HeeYoung

22.06.09 15:30:08

°¡³ª´Ù¶ó 0
Sanofi, Korea Vaccine, Boryeong Bio, GC Pharma

Sanofi Pasteur, Korea Vaccine, Boryung Biopharma, and GC Pharma are expected to participate in the free national vaccination (NIP) project for the 2022-2023 season organized by KCDA


Unlike the previous year, Sanofi Pasteur is expected to participate as a new business operator and Ilyang Pharmaceutical is expected to be excluded.

As a result of the bidding conducted through the Nara Market of the Public Procurement Service on the 9th, Sanofi Pasteur was selected as the first choice by writing the lowest price of 14,433. The desired quantity is 2.2 million doses.The second ranking is Korea Vaccine, which participated in 16,670 won, and the desired quantity is 1.7 million doses. The third place is Boryung Bio Pharma, which spent 16,887 won, and the desired quantity is 1.8 million degrees. The fourth ranking was GC Pharma, which offered 10,700 won, and the desired quantity was 6 millio

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)